Your browser doesn't support javascript.
loading
Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study.
McClymont, E; Atkinson, A; Albert, A; Av-Gay, G; Andrade, J; Barrett, J; Bogler, T; Boucoiran, I; Castillo, E; D'Souza, R; El-Chaâr, D; Fadel, S; Fell, D B; Korchinski, I; Kuret, V; Ogilvie, G; Poliquin, V; Sadarangani, M; Scott, H; Snelgrove, J W; Tunde-Byass, M; Money, D.
Afiliación
  • McClymont E; Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada.
  • Atkinson A; Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada.
  • Albert A; Women's Health Research Institute, Vancouver, Canada.
  • Av-Gay G; Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada.
  • Andrade J; Women's Health Research Institute, Vancouver, Canada.
  • Barrett J; Department of Obstetrics & Gynecology, McMaster University, Hamilton, Canada.
  • Bogler T; Department of Family & Community Medicine, University of Toronto, Toronto, Canada.
  • Boucoiran I; Department of Obstetrics & Gynecology and School of Public Health, Université de Montréal, Montreal, Canada.
  • Castillo E; Department of Obstetrics & Gynecology, University of Calgary, Calgary, Canada.
  • D'Souza R; Department of Obstetrics & Gynecology, University of Toronto, Toronto, Canada.
  • El-Chaâr D; Department of Obstetrics & Gynecology, University of Ottawa, Ottawa, Canada.
  • Fadel S; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Fell DB; School of Epidemiology & Public Health, University of Ottawa, Ottawa, Canada.
  • Korchinski I; Women's Health Research Institute, Vancouver, Canada.
  • Kuret V; Department of Obstetrics & Gynecology, University of Calgary, Calgary, Canada.
  • Ogilvie G; School of Population & Public Health, University of British Columbia, Vancouver, Canada.
  • Poliquin V; Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Manitoba, Winnipeg, Canada.
  • Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada.
  • Scott H; Department of Obstetrics & Gynecology, Dalhousie University, Halifax, Canada.
  • Snelgrove JW; Department of Obstetrics & Gynecology, University of Toronto, Toronto, Canada.
  • Tunde-Byass M; Department of Obstetrics & Gynecology, University of Toronto, Toronto, Canada.
  • Money D; Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada; Women's Health Research Institute, Vancouver, Canada. Electronic address: deborah.money@ubc.ca.
Vaccine ; 41(48): 7183-7191, 2023 11 22.
Article en En | MEDLINE | ID: mdl-37865598
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Adult / Female / Humans / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Adult / Female / Humans / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Canadá